Related Experiment Video
Updated: Apr 9, 2026

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
Published on: October 14, 2016
Rhabdomyosarcoma of the temporal bone in children - a systematic review
Agata Gierlotka1, Ireneusz Bielecki1, Estera Jagosz-Kandziora1
1Department of Pediatric Otolaryngology, Head and Neck Surgery, Medical University of Silesia, Katowice, Poland.
Insights
Pediatric temporal bone rhabdomyosarcoma is a rare, aggressive cancer often mistaken for ear infections. Early imaging and biopsy are crucial for timely diagnosis and better outcomes in children presenting with persistent ear symptoms and facial nerve palsy.
Area of Science:
- Pediatric Oncology
- Otolaryngology
- Medical Imaging
Background:
- Rhabdomyosarcoma of the temporal bone and middle ear is a rare pediatric malignancy.
- It frequently mimics chronic otitis media, leading to delayed diagnosis and advanced disease.
- This condition requires a high index of suspicion in pediatric patients with persistent otologic symptoms.
Purpose of the Study:
- To review the epidemiology, clinical presentation, imaging features, staging, treatment, and outcomes of pediatric temporal bone rhabdomyosarcoma.
- To enhance understanding of this rare but aggressive childhood cancer.
- To inform clinical practice regarding diagnosis and management.
Main Methods:
- A comprehensive literature review was performed using Embase, MEDLINE (PubMed), Cochrane Library, and ScienceDirect.
- Articles published between 2000 and 2025 were screened for relevance.
- Inclusion criteria focused on histopathologically confirmed cases in patients aged 0-18 years with available imaging and clinical data.
Main Results:
- Analysis of 35 studies involving 68 pediatric patients revealed common symptoms: persistent otorrhea (73%), otalgia (42%), hearing loss, and aural polyps.
- Facial nerve palsy was present in 69% of cases.
- Imaging typically showed an osteolytic soft-tissue mass in the middle ear/mastoid, often with skull base or intracranial extension. Standard treatment involved chemotherapy and radiotherapy.
Conclusions:
- Temporal bone rhabdomyosarcoma should be considered in the differential diagnosis of persistent pediatric otologic symptoms, especially with facial nerve palsy or poor response to treatment.
- Early diagnostic imaging and biopsy are critical for prompt diagnosis.
- Timely intervention can lead to improved patient outcomes.
Background:
Rhabdomyosarcoma of the temporal bone and middle ear is a rare but aggressive pediatric malignancy that often mimics chronic otitis media, resulting in delayed diagnosis and advanced disease at presentation.
Objective:
To summarize the epidemiology, clinical presentation, imaging characteristics, staging, management strategies, and outcomes of pediatric temporal bone rhabdomyosarcoma.
Methods:
A review was conducted using Embase (Ovid), MEDLINE (PubMed), Cochrane Library, and ScienceDirect databases. Articles published between 2000 and 2025 were screened. Inclusion criteria comprised histopathologically confirmed rhabdomyosarcoma involving the temporal bone or middle ear in patients aged 0-18 years, with documented imaging and clinical data.
Results:
Thirty-five studies, including 68 pediatric patients, were analyzed. The most common presenting symptoms were persistent otorrhea (73%), otalgia (42%), hearing loss, and aural polyps. Facial nerve palsy occurred in 69% of cases. Imaging demonstrated an osteolytic soft-tissue mass involving the middle ear and mastoid, often with skull base or intracranial extension. Chemotherapy combined with radiotherapy was the standard treatment approach.
Conclusion:
Temporal bone rhabdomyosarcoma in children should be considered in the differential diagnosis of persistent otologic symptoms, particularly when associated with facial nerve palsy or a poor response to standard therapy. Early imaging and biopsy are essential for early diagnosis and improved outcomes.
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
